Organization
Department of Clinical Medicine and Surgery, Università Federico II, Napoli, Italy
7 abstracts
Abstract
Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial.Org: Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Clinical Medicine and Surgery, Università Federico II, Napoli, Italy, Medical Oncology Department, ASL FR, Frosinone, Italy, Precision Medicine Unit in Senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy,
Abstract
Biomarker assessment and pharmacology of HP518, an AR PROTAC degrader from the phase 1 dose-escalation study in patients with metastatic castration-resistant prostate cancer (mCRPC).Org: Peter MacCallum Cancer Centre, Melbourne, Australia, Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre & Rural Medical School, Albury Campus, University of New South Wales, Albury-Wodonga, NSW, Australia, Department of Clinical Medicine and Surgery, Università Federico II, Napoli, Italy, Chris O'Brien Lifehouse, The Alfred Hospital,
Abstract
A first-in-human phase I, dose-escalation and dose-expansion study of SY-5007, a highly potent and selective RET inhibitor, in Chinese patients with advanced RET positive solid tumors.Org: Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, Clinical Trial Center and Department of Epidemiology - IRCCS Ospedale Policlinico San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, Lung Cancer Department, The First Affiliated Hospital of Xiamen University,
Abstract
Artificial intelligence algorithm developed to predict immune checkpoint inhibitors efficacy in non–small-cell lung cancer.Org: University Hospital of North Norway, UiT The Arctic University of Norway, Brigham and Women's Hospital/Massachusetts General Hospital, Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology,
Abstract
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).Org: IRCCS Ospedale Policlinico San Martino, Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, UOC Oncologia Medica,
Abstract
A MACHINE LEARNING MODEL FOR IDENTIFYING IMPORTANT CLINICAL VARIABLES AND PREDICTING ONE-YEAR TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS PERFORMING AN INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHOrg: ZiteLab ApS, University Hospital of Copenhagen Rigshospitalet, DANBIO, Dept of Rheumatology, University hospital, Hvidovre, Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Center for Rheumatology and Spine Diseases,
Abstract
ANTIBODY-BASED PROXIMITY LIGATION ASSAY COMBINED WITH FLOW CYTOMETRY IS A POWERFUL TOOL TO DETECT ACTIVE IL-7 RECEPTORS IN ARTHRITIS Org: Department of Biomedicine, University of Basel, Department of Clinical Medicine and Surgery, Università Federico II, Napoli, Italy, Department of Molecular Biology and Genetics, Aarhus University, Department of Rheumatology, Aarhus University Hospital, Aarhus C, Denmark,